Sunshine Biopharma (SBFM) EPS (Diluted) (2017 - 2026)

Sunshine Biopharma (SBFM) EPS (Diluted) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 0.31
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.42
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -1.49
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 5.82
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 0.15
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.91
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 0.11
10 Sunshine Biopharma 750,608.81 -6.16 Mn 2.18 Mn -3.17

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.17
Dec 31, 2025 -5.45
Sep 30, 2025 0.75
Jun 30, 2025 -8.19
Mar 31, 2025 -4.36
Dec 31, 2024 -30.75
Sep 30, 2024 -9.45
Jun 30, 2024 -357.55
Mar 31, 2024 -400.31
Dec 31, 2023 -995.87
Sep 30, 2023 -506.99
Jun 30, 2023 -711.44
Mar 31, 2023 -1,544.85
Dec 31, 2022 -30,978.02
Sep 30, 2022 -1,543.45
Jun 30, 2022 -680.39
Mar 31, 2022 -4,682.70
Dec 31, 2021 5,092.49
Dec 31, 2019 193,375.00
Jun 30, 2019 1,406.00